Journal article
Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy
European review for medical and pharmacological sciences, Vol.25(10), pp.3923-3932
01/01/2021
DOI: 10.26355/eurrev_202105_25963
PMID: 34109607
Abstract
Angiotensin converting enzyme 2 (ACE2) has potentially conflicting roles in health and disease. COVID-19 coronavirus binds to human cells via ACE2 receptor, which is expressed on almost all body organs. Boosting the ACE2 receptor levels on heart and lung cells may provide more cellular enter to virus thereby worsening the infection. Therefore, among the drug targets, ACE2 is suggested as a vital target of COVID-19 therapy. This hypothesis is based on the protective role of the drugs acting on ACE2. Therefore, this review discusses the impact and challenges of using ACE2 as a target in the current therapy of COVID-19.
Details
- Title: Subtitle
- Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy
- Creators
- H. F. Hetta - University of Cincinnati Medical CenterK. Muhammad - United Arab Emirates UniversityA. M. Algammal - Suez Canal UniversityH. Ramadan - USDADARS, Bacterial Epidemiol & Antimicrobial Resistance R, Us Natl Poultry Res Ctr, Athens, GA USAM. S. Abdel-Rahman - Assiut UniversityM. Mabrok - Suez Canal UniversityG. Koneru - Rutgers State Univ, Rutger New Jersey Med Sch, Dept Med, Div Gastroenterol & Hepatol, New Brunswick, NJ USAA. A. Elkady - Sohag UniversityG. El-Saber Batiha - Damanhour UniversityY. Waheed - Foundation University IslamabadN. Munawar - United Arab Emirates UniversityH. S. M. Farghaly - Assiut University
- Resource Type
- Journal article
- Publication Details
- European review for medical and pharmacological sciences, Vol.25(10), pp.3923-3932
- Publisher
- Verduci Publisher
- DOI
- 10.26355/eurrev_202105_25963
- PMID
- 34109607
- ISSN
- 1128-3602
- eISSN
- 2284-0729
- Number of pages
- 10
- Language
- English
- Date published
- 01/01/2021
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984359664802771
Metrics
4 Record Views